Dr. Holger N. Reithinger

November 22, 2016
Interview from #BIOEurope 2016 in Cologne: Venture capital firm Forbion with about EUR 700 million under management is based in The Netherlands and Germany. The company’s investment areas are biotech, medical devices and diagnostics. They are looking for seven to eight investments in the near term and seeing many opportunities in Europe. Forbion is seeing a growth in university cutting-edge spinouts. Website: https://forbion.com/
Previous Video
BIO-Europe® 2016: Neovacs CEO outlines clinical timeline for lupus drug
BIO-Europe® 2016: Neovacs CEO outlines clinical timeline for lupus drug

Miguel Sieler, CEO of 25-year-old French vaccines company Neovacs, chats with Mike Ward, global director of...

Next Video
TVM - Making Waves
TVM - Making Waves

Interview from #BIOEurope 2016 in Cologne: TVM is one of the longest-standing VCs in Europe, with offices i...